← Back to guidelines
Gastroenterology25 papers

Normoprolactinemic galactorrhea

Last edited: 4/15/2026

Overview

Galactorrhea, the spontaneous flow of milk from the breast in the absence of childbirth or breastfeeding, can occur in normoprolactinemic states, often linked to medication use without elevated prolactin levels 12.

Diagnosis

  • Presence of milk secretion from the breast without pregnancy or lactation
  • Normal prolactin levels (euprolactinemia) confirmed by laboratory testing
  • History of medication use, particularly antipsychotics, antidepressants, and domperidone 12
  • Exclusion of other causes such as tumors, hypothyroidism, or pituitary disorders
  • Management

  • Discontinuation or adjustment of offending medications: If galactorrhea is medication-induced, tapering or switching the drug may resolve symptoms 12
  • Monitoring: Regular follow-up to assess resolution of symptoms and prolactin levels 1
  • Supportive care: Addressing patient concerns and providing reassurance [Expert opinion]
  • Special Populations

  • Pediatrics: Euprolactinemic galactorrhea secondary to domperidone has been reported in adolescents, highlighting the need for careful monitoring in this age group 2
  • No specific recommendations for pregnancy or elderly populations based on provided abstracts
  • Key Recommendations

  • Identify and discontinue or adjust medications known to cause galactorrhea, particularly antipsychotics like risperidone and domperidone (Evidence: Moderate) 12
  • Confirm euprolactinemia through laboratory testing to rule out hyperprolactinemia as a cause (Evidence: Moderate) 1
  • Monitor patients closely for symptom resolution post-medication adjustment (Evidence: Expert opinion)
  • References

    1 Liu Y, Hu D, Lu Y, Li Y, Li Y, Liu M. Global large-scale real-world assessment of drug-associated galactorrhea based on FDA adverse drug reaction reports. Pakistan journal of pharmaceutical sciences 2026. link 2 Demir AM, Kuloglu Z, Berberoglu M, Kansu A. Euprolactinemic galactorrhea secondary to domperidone treatment. Journal of pediatric endocrinology & metabolism : JPEM 2015. link

    Original source

    1. [1]
      Global large-scale real-world assessment of drug-associated galactorrhea based on FDA adverse drug reaction reports.Liu Y, Hu D, Lu Y, Li Y, Li Y, Liu M Pakistan journal of pharmaceutical sciences (2026)
    2. [2]
      Euprolactinemic galactorrhea secondary to domperidone treatment.Demir AM, Kuloglu Z, Berberoglu M, Kansu A Journal of pediatric endocrinology & metabolism : JPEM (2015)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG